| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Richy Agajanian last filed a Form 4 in June 2022, as 10% Owner at TOI. Richy Agajanian's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 253,436 shares of TOI. The TOI filings lean toward selling, a net 1,600,000 shares.
Richy Agajanian has 2 Form 4 filings on record from May 2022 to June 2022, all as 10% Owner at Oncology Institute (TOI), 2022.
The 3 reported transactions were 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $9.6M.
The only open-market sale was 1,600,000 shares of TOI at an average $6.00 on May 11, 2022, about $9.6M. Twelve months later TOI was down 91%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 1,600,000 | $6.00 | $9,600,000.00 | -86.3% | +18.0% | -91.2% |